Pages that link to "Q40685677"
Jump to navigation
Jump to search
The following pages link to Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers (Q40685677):
Displaying 50 items.
- The role of SPINK1 in ETS rearrangement-negative prostate cancers (Q24647020) (← links)
- Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer (Q24650647) (← links)
- Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers (Q26766271) (← links)
- Recurrent rearrangements in prostate cancer: causes and therapeutic potential (Q26851525) (← links)
- Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue (Q26997884) (← links)
- Role of the TMPRSS2-ERG gene fusion in prostate cancer (Q28269156) (← links)
- YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion (Q28477993) (← links)
- Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines (Q28771722) (← links)
- Prognostic outlier genes for enhanced prostate cancer treatment (Q30244674) (← links)
- Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1. (Q30427325) (← links)
- Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer (Q33359279) (← links)
- Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy (Q33361134) (← links)
- Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer (Q33594473) (← links)
- Evaluating translocation gene fusions by SNP array data (Q34132911) (← links)
- 5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancer (Q34614232) (← links)
- Oncogenic gene fusions in epithelial carcinomas (Q34949690) (← links)
- Early human prostate adenocarcinomas harbor androgen-independent cancer cells (Q35005020) (← links)
- Androgen receptor signaling in prostate cancer development and progression (Q35183663) (← links)
- Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells (Q35199287) (← links)
- TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features (Q36147719) (← links)
- Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models (Q36435777) (← links)
- Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer (Q36610777) (← links)
- ERG rearrangement as a novel marker for predicting the extra-prostatic extension of clinically localised prostate cancer (Q36741911) (← links)
- A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer (Q36784513) (← links)
- Fusion in the ETS gene family and prostate cancer (Q36882701) (← links)
- The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis (Q36899790) (← links)
- Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma (Q36901964) (← links)
- Common gene rearrangements in prostate cancer (Q36920169) (← links)
- A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants (Q36972104) (← links)
- TMPRSS2-ETS fusion prostate cancer: biological and clinical implications (Q36983532) (← links)
- Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts (Q37003441) (← links)
- TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry. (Q37046014) (← links)
- ETS rearrangements in prostate cancer (Q37047029) (← links)
- Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India (Q37054053) (← links)
- Is it important to decipher the heterogeneity of "normal karyotype AML"? (Q37110802) (← links)
- Genetic variation in the upstream region of ERG and prostate cancer (Q37127440) (← links)
- Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men. (Q37139054) (← links)
- The discovery and application of gene fusions in prostate cancer (Q37142194) (← links)
- Clinical utility of prostate carcinoma molecular diagnostic tests. (Q37159136) (← links)
- Recurrent gene fusions in prostate cancer (Q37194503) (← links)
- Translocations in epithelial cancers (Q37363960) (← links)
- Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma (Q37383449) (← links)
- A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer (Q37383453) (← links)
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression (Q37383459) (← links)
- New and novel markers for prostate cancer detection (Q37446023) (← links)
- Urine markers in monitoring for prostate cancer. (Q37571461) (← links)
- ETS gene fusions in prostate cancer (Q37573395) (← links)
- Biomarkers for prostate cancer detection (Q37656233) (← links)
- Discovery of prostate cancer biomarkers by microarray gene expression profiling (Q37656262) (← links)
- Cytogenetics and genetics of human cancer: methods and accomplishments (Q37820734) (← links)